Veeda Lifesciences

March is Multiple Myeloma Awareness Month—a time to amplify our efforts in raising awareness and supporting those affected by this challenging condition. At Veeda Lifesciences , we remain dedicated to advancing research, expanding access to innovative treatments, and driving better outcomes for patients. Let’s continue working towards a future of improved care and hope for the Myeloma community. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #MultipleMyelomaAwarenessMonth #MultipleMyeloma #CancerAwareness #BloodCancer #AwarenessMonth #Treatment #Veeda #VeedaLifesciences

Insulin Aspart has emerged as one of the promising therapies for both type 1 and type 2 diabetes. Its rapid-acting properties has become an effective management tool by improving glycemic control, ensuring better and faster blood sugar regulation.   In a recent article published in Clinical Pharmacology in Drug Development, Veeda Expert Dr. Hiren Mehta co-authored a study demonstrating how Insulin Aspart achieves faster subcutaneous absorption compared to regular insulin, paving the way for enhanced biosimilarity and improved patient outcomes. - Title: Equivalence of Biosimilarity in Pharmacokinetic and Pharmacodynamic Properties of Recombinant Human Insulin Aspart - Authors: Sneha A. Dongre, Gauri A. Kulkarni, Damodar Thapa, Nikhil Ghade, Jeseena Lona, Hiren Prajapati, Hiren Mehta, Swati Guttikar, Archana R. Krishnan, Sanjay M. Sonar   Read the Article Now: https://bit.ly/4kEtilr To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #Veeda #VeedaLifesciences #DrugDevelopment #ScientificArticle #ClinicalAffairs #Biosimilarity

𝐌𝐞𝐞𝐭 𝐕𝐞𝐞𝐝𝐚 𝐋𝐢𝐟𝐞𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐚𝐭 𝐒𝐰𝐢𝐬𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐃𝐚𝐲 2025 We are excited to be a part of Swiss Biotech Day 2025, one of Europe’s leading biotechnology conferences, on May 5-6, 2025, at Congress Centre Basel, Switzerland. At Veeda Lifesciences, we combine end-to-end clinical trial services with advanced technology to support (Bio)Pharma in bringing new therapies to market. Here’s how we’re making a difference: One-Stop CRO Solutions: Comprehensive services under one roof, covering preclinical research, early and late-phase trials, bioanalytical research, and pharmacovigilance. Full-Service Capabilities: From study design and patient recruitment to site management, data management, and regulatory support, ensuring seamless trial execution. Biopharma Expertise: Specialized bioanalysis and analytical sciences for biotherapeutics, delivering precise PK, PD, immunogenicity, and biomarker insights to advance biologics and biosimilars. Tech-Powered Efficiency: AI-driven recruitment, real-world data integration, and advanced clinical trial management systems to optimize processes and reduce timelines. Let’s Connect! Meet André Bongartz, Director of Business Development, to explore how Veeda can support your clinical research goals. Schedule a Meeting Here: https://bit.ly/4gCPpFH To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #SwissBiotechDay #ClinicalTrials #Biopharma #DrugDevelopment #ClinicalBioanalysis #VeedaLifesciences

DCAT Week is here, and our excitement is off the charts!   Our team has touched down in New York and can’t wait to meet our esteemed partners, welcome new collaborators, and reconnect with cherished friends.   Let’s talk about how our deep expertise, strategic study designs, and robust infrastructure can maximize your first-to-market potential —schedule a meeting with us now - https://bit.ly/4gCPpFH Mahesh Bhalgat Melissa Peloquin DCAT (Drug, Chemical & Associated Technologies Association) To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #DCATWeek #Veeda #DCATWeek2025 #VeedaLifesciences #biotherapeutics #generics

🌟 Veeda Lifesciences GCP Training Success! 🌟 We are happy to share that over 820 employees at our Ahmedabad and Mehsana locations have successfully completed the mandatory regulatory training on Good Clinical Practices (GCP). This comprehensive 3-day training was conducted by the esteemed Dr. Mira Desai, Former Professor & Head of Pharmacology at B.J. Medical College, Ahmedabad, and CDSCO-appointed expert for inspection & training of clinical research facilities. The training focused on: ICH Harmonized Guideline for GCP E6 (R3) New Drugs and Clinical Trial Rules 2019 and its amendments Use of digital technology in clinical trials Our in-house training team also led insightful sessions on good clinical and good documentation practices, followed by an engaging open forum discussion. Catch a glimpse of the training program conducted for Veeda employees at Ahmedabad and Mehsana! #VeedaLifesciences #GCPTraining #ClinicalResearch #GoodClinicalPractices #DigitalHealth #ClinicalTrials #EmployeeDevelopment #Pharmacology #HealthcareInnovation #Ahmedabad #Mehsana Amee Kanuga Pranav Dalal Manmohansinh Chauhan Dr. Tulsi Das Mishra Dr. Jatin Vadhvana Devangi Dave Rachana Shah Dr. Vinita Verma Kinjal Kansara HARDIK PATEL Manish Dutt Ravindrasinh Gadhavi Dipen Barot Gaurav Kudpane

May the colors of Holi brighten your life and bring good health, happiness and prosperity. We wish you all a Happy Holi! #Veeda #VeedaLifesciences #Holi #HappyHoli #Holi2025 #FestivalOfColors

🌟 Industry-Academia Partnership: A Step Towards Practical Learning 🌟 We at Veeda Lifesciences were excited to host a group of 25 post-graduate students specializing in Pharmacology, NDDS, and Regulatory Affairs, along with two esteemed faculty members from the Institute of Pharmacy, National Forensic Sciences University (NFSU), at our USFDA-audited facility in Ahmedabad, India. These bright minds visited Veeda's phase 1 and bioanalytical research units to practical insights and understanding into clinical research, clinical trials, and BA/BE studies. Our in-house experts, Mr. Kiran Chauhan, Ms. Poonam Patel (Biopharmaceutics), Dr. Dharmesh Patel (Bioanalytical Research), Dr. Vaibhav D. P., and Dilip Patel (Clinical Research), shared their expertise, offering a comprehensive understanding of our USFDA-audited Vedant facility. The interactive discussions focused on the roles of Medical Writers and Regulatory Affairs professionals, as well as the functioning of our bioanalytical research laboratories and clinical research unit. Veeda's training and development team, led by Ms. Devangi Dave and subject matter experts - Ms. Kinjal Kansara, Mr. HARDIK PATEL, and Mr. Manish Dutt, ensured that the students had a memorable learning experience, gaining valuable practical insights into the nuances of a Contract Research Organization. We believe that such collaborations are crucial for bridging the gap between academic learning and industry practices, and we look forward to more such enriching interactions in the future. #IndustryAcademia #PharmacyEducation #ClinicalResearch #BioanalyticalResearch #VeedaLifesciences #StudentEngagement #PracticalLearning Mahesh Bhalgat Sanjib Banerjee, PhD Sapna Y. R. James Brook Kiran Marthak, Manmohansinh Chauhan, Prof. Manjunath Ghate, Dr.Jasmin Kubavat, Dr. Nishita Mistry, Vijay Kevlani, Ashutosh Kainthola, Ujala P., Satendra Rai, Akashi Patel, Dhruvi Shah, pavani brundha, Rushabh Doshi, Rudrika Gauswami, Lekha Dhake, Somya Rajput, Garima Sharma, Pranjal Sharma, Vruti Kapadiya, Biswanath Chand, AMLAN DAS, Kadimi Dhana Lakshmi Durga, Sarthak Sharma, swapnil joshi

Supporting Breakthroughs in Myeloma Science — Veeda Lifesciences is Sponsoring 6th European Myeloma Network Meeting. As a dedicated partner in 𝐡𝐞𝐦𝐚𝐭𝐨-𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡, we recognize the critical need for well-designed clinical trials to drive innovation and improve patient outcomes. With extensive experience in hematologic malignancies, we bring deep scientific and operational expertise to myeloma research. This year is even more special with 𝐄𝐌𝐍 2025 𝐢𝐧 𝐀𝐭𝐡𝐞𝐧𝐬, a city that holds a key presence for us. Through our work, we have navigated the complexities of hemato- oncology trials and witnessed firsthand the transformative impact of scientific advancements on treatment strategies and patient care. Let’s collaborate to push the boundaries of myeloma research. Mahesh Bhalgat , James Brook, George Kouvatseas, Faidra Psarommati, Ioannis Ninos, Eleni Vasalou, Angeliki Liossi Book a meeting now – https://bit.ly/4gCPpFH To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #EMN2025 #MultipleMyeloma #HematoOncology #ClinicalResearch #VeedaLifesciences

Phase I Trial Evaluating Novel Therapy for Diabetes Management Recently, Veeda Lifesciences supported the IND filing for a novel molecule targeting diabetes management in adults, adolescents, and children aged 2 years and above. We provided comprehensive support for both Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) studies, with a special focus on insulin and GLP-1 responses. The study was completed successfully within the designated timeline, meeting all regulatory submission requirements without any major safety concerns. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #VeedaLifesciences #Veeda #PhaseITrial #DiabetesManagement #NovelTherapy #CaseStudy #VeedaLifesciencesStudies

🌟Pioneering Academic Engagement and Technological Innovation 🌟 We are proud to highlight our ongoing academic engagement initiatives, exemplified by Dr. Kiran Marthak's recent presentation at the 6th National Conference of Institute of Pharmacy (NCIP) 2025, organized by Nirma University. Dr. Marthak delivered an inspiring talk on "Harnessing Artificial Intelligence/Machine Learning in Pharmaceutical Innovations to Address Global Health Challenges," emphasizing the pivotal role of Contract Research Organizations (CROs) in driving breakthroughs in drug discovery, personalized medicine, diagnostics, and global healthcare solutions through AI and ML. During his presentation, Dr. Marthak shared several compelling examples and case studies, offering deep insights into cutting-edge research and practical applications of AI in the pharmaceutical industry. He highlighted how AI and ML are being leveraged to address key health challenges and global health inequalities, showcasing Veeda Lifesciences' commitment to innovation and excellence. The conference featured talk and presentation from leading industry experts including Dr. Raghu Rangaswamy, Dr. A. Sankaranarayanan, Dr. Shrinivas Savale, Dr. Jayathirtha Gopalakrishna, Ph. D., Dr. Shubhini Saraf, Dr. Ketan Kotecha, Dr. Javed Ali and Dr. Sanjay Kumar, Ph. D. At Veeda Lifesciences, we believe that academic engagement is crucial for advancing pharmaceutical research and development. Our collaborations with academic institutions, such as Nirma University, enable us to stay at the forefront of technological advancements and integrate the latest scientific discoveries into our work. By fostering strong partnerships with academia, we aim to drive high-quality pharma innovations and encourage the next generation of scientists and researchers. Our efforts in leveraging technology for pharmaceutical R&D are focused on enhancing drug discovery processes and developing personalized treatment solutions. #VeedaLifesciences #AcademicEngagement #PharmaInnovation #AI #MachineLearning #HealthcareSolutions #GlobalHealth Mahesh Bhalgat Sanjib Banerjee, PhD Sapna Y. R. BIONEEDS INDIA PRIVATE LIMITED Heads James Brook Tandon, Ajay Pranav Dalal Amee Kanuga Manmohansinh Chauhan Devangi Dave